drugset / Trial / NCT07278323

Frozen Shoulder and Hormone Replacement Therapy

NCT07278323

Phase 4 Recruiting 60 enrolled University of California, San Francisco
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effects of hormone replacement therapy (HRT) in addition to standard treatment on frozen shoulder symptoms in women with age-related changes to their menstrual cycle. Frozen shoulder refers to the condition a doctor diagnosed the participant with regarding shoulder pain, stiffness, and progressive loss of range of motion. Age-related menstrual cycle changes, known as perimenopause and/or menopause, refers to a change or stoppage of monthly menstrual cycles. Other symptoms participants may be experiencing include vaginal dryness, hot flashes, or night sweats. Hormone replacement therapy (HRT) refers to medicine with female hormones in it. For this study, HRT will be in the form of a patch that goes on the skin and a daily oral pill. Participants will be randomly assigned to receive either HRT plus standard care, or only standard care. Follow-up tests will be completed at 6 months of treatment to assess participant progress.

Timeline

Start
2026-01-15
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.5 mg Other
Background Lidocaine Other / unclassified 1 % Other
Background Ropivacaine Other / unclassified 0.2 % Other
Background Triamcinolone Other / unclassified 40 mg/ml Other

Indications